Comprehensive high quality database containing reproductive and developmental studies
**Produced under a CRADA with FDA Center for Drug Evaluation and Research (CDER)
Includes 58 drugs and drug products filed in New Drug
application (NDA) reviews.
Test system includes mostly rats and studies include
mostly Segment II (Developmental) studies.
The compounds are stratified across carcinogenic and
genotoxic potentials.
Studies include:
Maternal toxicity
Offspring toxicity
survival
growth
morphology
Access to the raw data in SD and XML file formats, using the public ToxML controlled vocabulary.
A database viewer is provided with the data and requires Windows 2000 or XP with at least a PIII 700MHz processor (or equivalent) with 256MB of RAM and 500MB of disk space.